product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human FGF basic/FGF2/bFGF, 145 aa TC Grade, CF
catalog :
4114-TC-01M
quantity :
1 mg
price :
1037 USD
more info or order :
R&D Systems product webpage
citations: 30
Reference
Lin P, Chen W, Long Z, Yu J, Yang J, Xia Z, et al. RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation. Cell Discov. 2024;10:32 pubmed publisher
Yin J, Seo Y, Rhim J, Jin X, Kim T, Kim S, et al. Cross-talk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells. Cancer Res. 2023;83:3693-3709 pubmed publisher
Tian J, Huang C, Eslami F, Mannino M, Mai R, Hart G. Regulation of Primary Cilium Length by O-GlcNAc during Neuronal Development in a Human Neuron Model. Cells. 2023;12: pubmed publisher
Yuan H, Wu X, Wu Q, Chatoff A, Megill E, Gao J, et al. Lysine catabolism reprograms tumour immunity through histone crotonylation. Nature. 2023;617:818-826 pubmed publisher
Cuevas E, Guzman A, Burks S, Ramirez Lee A, Ali S, Imam S. Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model. Toxicol Rep. 2022;9:806-813 pubmed publisher
Kim E, Kim J, Kim S, Hong N, Choi S, Park M, et al. The oncogenic JAG1 intracellular domain is a transcriptional cofactor that acts in concert with DDX17/SMAD3/TGIF2. Cell Rep. 2022;41:111626 pubmed publisher
Mahoney Sanchez L, Bouchaoui H, Boussaad I, Jonneaux A, Timmerman K, Berdeaux O, et al. Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition. Cell Rep. 2022;40:111231 pubmed publisher
Sardar D, Chen H, Reyes A, Varadharajan S, Jain A, Mohila C, et al. Sox9 directs divergent epigenomic states in brain tumor subtypes. Proc Natl Acad Sci U S A. 2022;119:e2202015119 pubmed publisher
Kobayashi M, Kobayashi M, Odajima J, Shioda K, Hwang Y, Sasaki K, et al. Expanding homogeneous culture of human primordial germ cell-like cells maintaining germline features without serum or feeder layers. Stem Cell Reports. 2022;17:507-521 pubmed publisher
Zhai K, Huang Z, Huang Q, Tao W, Fang X, Zhang A, et al. Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells. Nat Cancer. 2021;2:1136-1151 pubmed publisher
Cho A, Jin Y, An Y, Kim J, Choi Y, Lee J, et al. Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids. Nat Commun. 2021;12:4730 pubmed publisher
Kim S, Lee S, Kim Y, Park J, Woo D, Kim D, et al. Tanc2-mediated mTOR inhibition balances mTORC1/2 signaling in the developing mouse brain and human neurons. Nat Commun. 2021;12:2695 pubmed publisher
Jerby Arnon L, Neftel C, Shore M, Weisman H, Mathewson N, McBride M, et al. Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma. Nat Med. 2021;27:289-300 pubmed publisher
Bae M, Roh J, Kim Y, Kim S, Han H, Yang E, et al. SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function. EMBO Mol Med. 2021;13:e12632 pubmed publisher
Tao W, Zhang A, Zhai K, Huang Z, Huang H, Zhou W, et al. SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells. EMBO Mol Med. 2020;12:e12291 pubmed publisher
Obara E, Aguilar Morante D, Rasmussen R, Frias A, Vitting Serup K, Lim Y, et al. SPT6-driven error-free DNA repair safeguards genomic stability of glioblastoma cancer stem-like cells. Nat Commun. 2020;11:4709 pubmed publisher
Zhang L, Avery J, Yin A, Singh A, Cliff T, Yin H, et al. Generation of Functional Brown Adipocytes from Human Pluripotent Stem Cells via Progression through a Paraxial Mesoderm State. Cell Stem Cell. 2020;27:784-797.e11 pubmed publisher
Zhu H, Blum R, Bernareggi D, Ask E, Wu Z, Hoel H, et al. Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity. Cell Stem Cell. 2020;27:224-237.e6 pubmed publisher
Singh A, Zhang L, Avery J, Yin A, Du Y, Wang H, et al. Human beige adipocytes for drug discovery and cell therapy in metabolic diseases. Nat Commun. 2020;11:2758 pubmed publisher
Micali N, Kim S, Diaz Bustamante M, Stein O Brien G, Seo S, Shin J, et al. Variation of Human Neural Stem Cells Generating Organizer States In Vitro before Committing to Cortical Excitatory or Inhibitory Neuronal Fates. Cell Rep. 2020;31:107599 pubmed publisher
Cholewa Waclaw J, Shah R, Webb S, Chhatbar K, Ramsahoye B, Pusch O, et al. Quantitative modelling predicts the impact of DNA methylation on RNA polymerase II traffic. Proc Natl Acad Sci U S A. 2019;116:14995-15000 pubmed publisher
Bernatchez J, Coste M, Beck S, Wells G, Luna L, Clark A, et al. Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells. Viruses. 2019;11: pubmed publisher
Beck S, Zhu Z, Oliveira M, Smith D, Rich J, Bernatchez J, et al. Mechanism of Action of Methotrexate Against Zika Virus. Viruses. 2019;11: pubmed publisher
Colunga T, Hayworth M, Kreß S, Reynolds D, Chen L, Nazor K, et al. Human Pluripotent Stem Cell-Derived Multipotent Vascular Progenitors of the Mesothelium Lineage Have Utility in Tissue Engineering and Repair. Cell Rep. 2019;26:2566-2579.e10 pubmed publisher
Bernatchez J, Yang Z, Coste M, Li J, Beck S, Liu Y, et al. Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus. Antimicrob Agents Chemother. 2018;62: pubmed publisher
Wang X, Prager B, Wu Q, Kim L, Gimple R, Shi Y, et al. Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. Cell Stem Cell. 2018;22:514-528.e5 pubmed publisher
Kim E, Cho J, Kim E, Kim Y. Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth. PLoS ONE. 2017;12:e0181183 pubmed publisher
Bullard Feibelman K, Govero J, Zhu Z, Salazar V, Veselinovic M, Diamond M, et al. The FDA-approved drug sofosbuvir inhibits Zika virus infection. Antiviral Res. 2017;137:134-140 pubmed publisher
Adepoju A, Micali N, Ogawa K, Hoeppner D, McKay R. FGF2 and insulin signaling converge to regulate cyclin D expression in multipotent neural stem cells. Stem Cells. 2014;32:770-8 pubmed publisher
West F, Machacek D, Boyd N, Pandiyan K, Robbins K, Stice S. Enrichment and differentiation of human germ-like cells mediated by feeder cells and basic fibroblast growth factor signaling. Stem Cells. 2008;26:2768-76 pubmed publisher
product information
brand :
R&D Systems, a Bio-Techne brand
catalog number base :
4114-TC
SKU :
4114-TC-01M
product name :
Recombinant Human FGF basic/FGF2/bFGF, 145 aa TC Grade, CF
description :
The Recombinant Human FGF basic/FGF2/bFGF, 145 aa TC Grade, CF from R&D Systems is derived from E. coli. The Recombinant Human FGF basic/FGF2/bFGF, 145 aa TC Grade, CF has been validated for the following applications: Bioactivity.
target :
FGF basic/FGF2/bFGF
unit size :
1 mg
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 µm filtered solution in Tris-HCl and NaCl.
conjugate :
Unconjugated
species :
Human
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
theoretical molecular weight :
16 kDa
gene symbol :
FGF2
details of functionality :
The protein is used at 20 ng/mL to support a 100-fold expansion of rat cortical neural stem cells or mouse cortical stem cells over 3 passages. Cells were cultured in N2 plus medium and supplemented with FGF basic every day. Measured in a cell proliferation assay using NR6R-3T3 mouse fibroblast cells. Raines, E.W. et al . (1985) Methods Enzymol. 109 :749. The ED50 for this effect is 0.3-3 ng/mL.
endotoxin note :
<0.01 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
NP_001997
applications :
Bioactivity
product keywords :
4114-TC, rhFGF basic, 145 aa TC, rh+FGF+basic, hFGF basic, rhFGF-2, hFGFb, hFGF-2, carrier-free, carrier free, 4114TC, cytokinegrowthfact, FGFbasic, FGFb, bFGF, FGF-AS, ASFGF2, cytokine, cytokines, FGF b, ss-FGF, -FGF, FGF, bFGF2, Fibroblast Growth Factor 2, Heparin-Binding Growth Factor 2, HBGF-2, bFGF, Prostatropin, Basic Fibroblast Growth Factor, NUDT6, GFG1
source :
E. coli-derived Recombinant Human FGF basic/FGF2/bFGF, 145 aa TC Grade, CF
extended description :
Analyzed by SEC-MALS
USD :
987
USD 2025 :
1037 USD
product details :
Analyzed by SEC-MALS
alt names :
Basic fibroblast growth factor, basic fibroblast growth factor bFGF, bFGF, FGF2, FGF-2, FGFBprostatropin, fibroblast growth factor 2 (basic), HBGF-2, heparin-binding growth factor 2, Prostatropin
more info or order :
R&D Systems product webpage
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.